Phase 2 Consolidation Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
A Study of QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients With Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy
Consolidation ImmunotherapyChemoradiotherapyLimited-stage Small Cell Lung Cancer (LS-SCLC)+1 more
Shanghai Chest Hospital28 enrolled1 locationNCT07091305
Recruiting
Phase 2
Combination of Concurrent Chemoradiotherapy With Surufatinib and Tislelizumab in Patients With Locally Advanced Non-Small Cell Lung Cancer
Non-small Cell Lung CancerTislelizumabConcurrent Chemoradiotherapy+2 more
Sun Yat-sen University80 enrolled1 locationNCT07086456
Recruiting
Phase 2
Tislelizumab Consolidation Therapy After Radiotherapy or Sequential Chemoradiation in Locally Advanced NSCLC Patients
Non-small Cell Lung CancerConsolidation ImmunotherapyRadiotherapy or Sequential Chemoradiation
Peking University Cancer Hospital & Institute20 enrolled1 locationNCT05758116
Completed
Phase 2
Selectively modulating emotional memories: Can Propranolol block reconsolidation of non-fearful, non-craving emotional memories?
Memory reconsolidation blockade with PropranololMemory consolidation blockade with Propranolol
Alain Brunet, PhD36 enrolled1 locationACTRN12616000131459